Related Experiment Videos
[Tolerance of 3.5 percent plasma protein solution]
Anasthesie, Intensivtherapie, Notfallmedizin
|August 1, 1986
Summary
This study found no evidence of sensitization to 3.5% plasma protein solution in patients. Allergy testing, including IgE antibody tests, showed negative results, indicating safety for this patient group.
Area of Science:
- Immunology
- Allergology
Context:
- Investigating potential adverse reactions to plasma protein solutions is crucial for patient safety.
- Identifying sensitization to specific blood products helps refine transfusion protocols.
Purpose:
- To assess the sensitization potential of 3.5% plasma protein solution in patients who received it without other blood derivatives or immunosuppressive treatment.
Summary:
- A prospective study screened 112 patients who received 3.5% plasma protein solution.
- Intracutaneous testing and serological tests (total IgE, specific IgE antibodies via PRIST and RAST) were performed on 68 consenting patients.
- No positive sensitization results were found, with only two patients showing transient or non-specific reactions.
Impact:
- These findings suggest that 3.5% plasma protein solution is unlikely to cause sensitization in the studied patient population.
- The results support the continued safe use of this plasma protein product.
- Further research could explore long-term effects or different patient cohorts.